Photon-counting CT in Chest Imaging (NCT07031336)
Photon-counting CT Post-processing Protocols for Robust Quantifications in Chest CT Scans
🩺 Plain-English Summary (8th-Grade Level)
Purpose and objective: This project aims to evaluate photon-counting computed tomography (PCCT) quantitative accuracy using COPDGene subjects. The goal is to establish acquisition protocols for PCCT scans with proper post-processing (e.g., reconstruction parameters and harmonization techniques) that enable reproducible measurements of emphysema metrics (e.g., Perc15, LAA-950, HU accuracy) and airways (Pi10, WA%) in the lungs. Study activities and population group: The study will recruit subjects from a current study at Duke (COPDGene Phase 4, Pro00113442). Here are the aims: * The research team will request consent from participants to acquire PCCT scans at their Phase 4 COPDGene visit. Scans will be performed using a PCCT-specific protocol. * Reconstruct the PCCT images with multiple post-acquisition parameter settings. Apply harmonization techniques that are recently developed by the investigators of this study. Data analysis: * Identify the reconstruction and harmonization conditions that enable reproducible measurements of emphysema metrics (perc15, LAA-950, HU accuracy) and airways (Pi10, WA%), when compared to the counterpart EICT scans. * Demonstrate the non-inferiority and potentially improved capabilities of PCCT scans in cross-sectional and longitudinal studies. Risk/safety issues: The participants are asked to get an additional CT scan with a PCCT scanner at their COPDGene Phase 4 visit. This additional CT scan will be done using an inspiratory chest protocol with a total of 3 mGy (\~1.5 mSv) radiation dose. This is roughly equivalent of 6 month of background radiation. Women who are pregnant will not have a chest CT scan done until they are confirmed to be not pregnant.
Who can join: Review the eligibility criteria below.
Location: Duke University Hospital — Durham, North Carolina
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Duke University Hospital — Durham, North Carolina
📞 Contact the Study Coordinator
Phone: (919) 668-8281
Email: wendy.curry@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in COPD (Chronic Obstructive Pulmonary Disease)
- Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD — Edmonton, Alberta
- Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD — Omaha, Nebraska
- Development And Evaluation of An Adaptive Web-Based Intervention for COPD — Aurora, Colorado
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia — Durham, North Carolina
- COPD Exacerbation Follow Up — Park Ridge, Illinois
- Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD — San Francisco, California
Explore by condition: All COPD (Chronic Obstructive Pulmonary Disease) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.